Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Intima-Media Thickness | 3 | 2024 | 108 | 1.080 |
Why?
|
| Carotid Artery Diseases | 2 | 2024 | 34 | 1.020 |
Why?
|
| Carotid Artery, Common | 1 | 2024 | 6 | 0.940 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 188 | 0.940 |
Why?
|
| Age Factors | 2 | 2024 | 370 | 0.250 |
Why?
|
| Aged | 4 | 2024 | 1740 | 0.240 |
Why?
|
| Dyslipidemias | 1 | 2024 | 57 | 0.220 |
Why?
|
| Sex Factors | 1 | 2024 | 227 | 0.220 |
Why?
|
| Risk Assessment | 1 | 2024 | 225 | 0.220 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2020 | 106 | 0.200 |
Why?
|
| Middle Aged | 5 | 2024 | 3601 | 0.200 |
Why?
|
| Risk Factors | 3 | 2024 | 1475 | 0.200 |
Why?
|
| Apolipoprotein B-100 | 1 | 2020 | 11 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 14 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2020 | 34 | 0.180 |
Why?
|
| Receptors, LDL | 1 | 2020 | 29 | 0.170 |
Why?
|
| Proprotein Convertase 9 | 1 | 2020 | 43 | 0.170 |
Why?
|
| Leg | 1 | 2019 | 21 | 0.160 |
Why?
|
| Ischemia | 1 | 2019 | 19 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 27 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2020 | 175 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 150 | 0.160 |
Why?
|
| Thrombosis | 1 | 2019 | 47 | 0.160 |
Why?
|
| Male | 5 | 2024 | 6754 | 0.160 |
Why?
|
| Stroke | 1 | 2019 | 62 | 0.160 |
Why?
|
| Adult | 5 | 2024 | 5913 | 0.150 |
Why?
|
| Female | 6 | 2024 | 9103 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2012 | 158 | 0.140 |
Why?
|
| Humans | 6 | 2024 | 14537 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2012 | 19 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2012 | 100 | 0.090 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 24 | 0.060 |
Why?
|
| Heptanoic Acids | 1 | 2004 | 10 | 0.060 |
Why?
|
| Pyrroles | 1 | 2004 | 12 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 22 | 0.060 |
Why?
|
| Heterozygote | 1 | 2004 | 43 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 29 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 468 | 0.050 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 83 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1422 | 0.050 |
Why?
|
| Heredity | 1 | 2020 | 6 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 89 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 158 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 176 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 327 | 0.040 |
Why?
|
| Critical Illness | 1 | 2019 | 44 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 1192 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1748 | 0.030 |
Why?
|
| Child | 1 | 2020 | 2242 | 0.030 |
Why?
|
| South Africa | 2 | 2020 | 7596 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2498 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 2985 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2012 | 317 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2005 | 6 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2005 | 31 | 0.020 |
Why?
|
| Neutrophils | 1 | 2005 | 53 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 171 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 14 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 188 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 7 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2004 | 25 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 125 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 96 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 419 | 0.010 |
Why?
|